文献速递角膜与眼表疾病神经眼科

大型城市医疗系统中带状疱疹眼病眼部并发症的危险因素与带状疱疹疫苗接种情况

Risk Factors for the Development of Ocular Complications in Herpes Zoster Ophthalmicus and Zoster Vaccine Utilization in a Large, Urban Health System.
PubMed 文献 · Am J Ophthalmol · 2024-10-01

在伊利诺伊大学医院系统2010年1月1日至2021年12月1日的回顾性队列研究中,3283例带状疱疹患者中110例(3.4%)发生带状疱疹眼病伴眼部受累,其中40例(36.4%)出现眼部并发症,最常见为角膜瘢痕(70%)。年龄、女性、初次就诊使用类固醇及基质角膜炎与眼部并发症发生相关;合格人群中仅5333例(1.5%)接种带状疱疹疫苗,43例接种后带状疱疹再激活。

要点

  • 带状疱疹眼病伴眼部受累患者中36.4%发生眼部并发症,最常见为角膜瘢痕(70%)。
  • 年龄、女性、初次就诊使用类固醇及基质角膜炎与眼部并发症发生相关。
  • 合格人群中带状疱疹疫苗接种率仅1.5%,43例接种后发生带状疱疹再激活。

核心结论

  • 在带状疱疹眼病中,年龄、女性、初次就诊使用类固醇及基质角膜炎与眼部并发症发生强烈相关。
  • 本研究人群中带状疱疹疫苗接种率低。
  • 了解带状疱疹/带状疱疹眼病并发症潜力与疫苗接种情况有助于识别高危人群以预防疾病。

研究设计与样本

  • 回顾性队列研究,纳入伊利诺伊大学医院系统2010年1月1日至2021年12月1日经诊断代码识别的带状疱疹及带状疱疹眼病患者。
  • 对诊断后1年内就诊的带状疱疹眼病患者病历进行摘录。
  • 采用多变量逻辑回归分析识别带状疱疹眼病眼部并发症发生的相关因素。

主要发现

  • 研究期间3283例患者患带状疱疹,平均发病年龄52.3岁,61.6%为女性,37%为黑人。
  • 带状疱疹眼病伴眼部受累见于110例(3.4%)患者。
  • 40例(36.4%)患者发生眼部并发症,最常见并发症为角膜瘢痕(70%)。
  • 年龄(OR 1.04,95%CI 1.0-1.1)、女性(OR 2.86,95%CI 1.0-8.1)、初次就诊使用类固醇(OR 4.46,95%CI 1.4-14.6)及基质角膜炎(OR 3.45,95%CI 1.2-9.8)与眼部并发症发生相关。
  • 合格人群中5333例(1.5%)接种带状疱疹疫苗;43例患者接种后发生带状疱疹再激活。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: To characterize the epidemiology of herpes zoster (HZ) and herpes zoster ophthalmicus (HZO) in an urban hospital system and determine risk factors associated with developing ocular complications in HZO. To report the frequency of shingles vaccination and HZ reactivation following shingles vaccination in this population. METHODS: A retrospective cohort study was conducted on patients seen at the University of Illinois Hospital system from January 1, 2010 to December 1, 2021 with HZ and HZO identified by diagnosis code. Charts of HZO patients seen within 1 year of diagnosis were abstracted. Multivariable logistic regression analysis identified factors associated with the development of ocular complications in HZO. RESULTS: During the study period, 3283 patients had HZ; mean age of onset was 52.3 years, 61.6% were female, and 37% were Black. HZO with ocular involvement was seen in 110 (3.4%) patients. Ocular complications developed in 40 (36.4%) patients; the most common complication was corneal scarring (70%). Age (odds ratio [OR] 1.04, 95%CI 1.0-1.1), female gender (OR 2.86, 95%CI 1.0-8.1), steroids at initial visit (4.46, 95%CI 1.4-14.6), and stromal keratitis (OR 3.45, 95% CI 1.2, 9.8) were associated with developing ocular complications. Of eligible populations, 5333 (1.5%) received shingles vaccination; 43 patients developed reactivation of HZ following vaccination. CONCLUSIONS: In HZO, age, female gender, steroids at initial visit, and stromal keratitis are strongly associated with developing ocular complications. Shingles vaccination rates were low in this study population. Understanding potential for complications in HZ/HZO and vaccination uptake can help identify at risk populations to prevent disease. NOTE: Publication of this article is sponsored by the American Ophthalmological Society.

来源:Am J Ophthalmol,查看原文。版权归原作者所有。

引用

  1. Lobo-Chan AM, Song A, Kadakia A, et al. Risk Factors for the Development of Ocular Complications in Herpes Zoster Ophthalmicus and Zoster Vaccine Utilization in a Large, Urban Health System. Am J Ophthalmol. 2024. PMID: 39362356. doi:10.1016/j.ajo.2024.09.028

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。